Alessandro Noseda
Direktor/Vorstandsmitglied bei REGENERX BIOPHARMACEUTICALS, INC.
Vermögen: - $ am 31.03.2024
Aktive Positionen von Alessandro Noseda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.04.2019 | - |
| Independent Dir/Board Member | 01.04.2019 | - | |
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 | - |
| Vorstandsvorsitzender | 01.01.2007 | 01.01.2017 | |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2018 | - |
| Corporate Officer/Principal | 01.01.1998 | 01.09.2018 | |
| Thule Therapeutics SA | Direktor/Vorstandsmitglied | - | - |
| Rostaquo | Direktor/Vorstandsmitglied | - | - |
| Metheresis Translational Research SA | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Alessandro Noseda
Ehemalige bekannte Positionen von Alessandro Noseda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Leadiant Biosciences SA
 Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Vorstandsvorsitzender | 01.01.2007 | 01.01.2017 |
Ausbildung von Alessandro Noseda
| Wake Forest School of Medicine | Doctorate Degree |
| University of Milan | Doctorate Degree |
Statistik
International
| Schweiz | 5 |
| Vereinigte Staaten | 4 |
| Italien | 3 |
Operativ
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
| Metheresis Translational Research SA | |
Leadiant Biosciences SA
Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Commercial Services |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Health Technology |
| Thule Therapeutics SA | |
| Rostaquo |
- Börse
- Insiders
- Alessandro Noseda
- Erfahrung
